Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (71-80 of 755) with videos related to

Pageof 76
Sort By:
Rheumatology (Oxford, England)|January 10, 2014
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targetsDaniel E Furst, Paul Emery
Clinics in Rheumatic Diseases|April 1, 1986
Implications of drug therapy in the elderlyJ Morgan, D E Furst
European Journal of Rheumatology|November 9, 2020
The burning question: To use or not to use cyclophosphamide in systemic sclerosisCosimo Bruni, Daniel E Furst
Clinical and Experimental Rheumatology|December 10, 1999
Pharmacotherapeutic strategies for disease-modifying antirheumatic drug (DMARD) combinations to treat rheumatoid arthritis (RA)T Münster, D E Furst
Bailliere'S Clinical Rheumatology|December 1, 1990
Methotrexate--the rapidly acting drugN Songsiridej, D E Furst
The Journal of Rheumatology|August 3, 2014
Rheumatoid arthritis: are current research-based guidelines clinically relevant?Suzanne Kafaja, Daniel E Furst
Rheumatology (Oxford, England)|April 5, 2008
Autoinflammatory diseases: an update of clinical and genetic aspectsQ Yao, D E Furst
The American Journal of Managed Care|April 17, 2008
Health-related quality of life in rheumatoid arthritisDaniel E Furst, Dinesh Khanna
Rheumatology (Oxford, England)|September 17, 2008
Pulmonary function testsJ Behr, D E Furst
Rheumatology (Oxford, England)|April 27, 2007
Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?K Brune, D E Furst
Pageof 76

Showing results (71-80 of 755) with videos related to

Sort By:
Pageof 76
Rheumatology (Oxford, England)|January 10, 2014
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targetsDaniel E Furst, Paul Emery
Clinics in Rheumatic Diseases|April 1, 1986
Implications of drug therapy in the elderlyJ Morgan, D E Furst
European Journal of Rheumatology|November 9, 2020
The burning question: To use or not to use cyclophosphamide in systemic sclerosisCosimo Bruni, Daniel E Furst
Clinical and Experimental Rheumatology|December 10, 1999
Pharmacotherapeutic strategies for disease-modifying antirheumatic drug (DMARD) combinations to treat rheumatoid arthritis (RA)T Münster, D E Furst
Bailliere'S Clinical Rheumatology|December 1, 1990
Methotrexate--the rapidly acting drugN Songsiridej, D E Furst
The Journal of Rheumatology|August 3, 2014
Rheumatoid arthritis: are current research-based guidelines clinically relevant?Suzanne Kafaja, Daniel E Furst
Rheumatology (Oxford, England)|April 5, 2008
Autoinflammatory diseases: an update of clinical and genetic aspectsQ Yao, D E Furst
The American Journal of Managed Care|April 17, 2008
Health-related quality of life in rheumatoid arthritisDaniel E Furst, Dinesh Khanna
Rheumatology (Oxford, England)|September 17, 2008
Pulmonary function testsJ Behr, D E Furst
Rheumatology (Oxford, England)|April 27, 2007
Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?K Brune, D E Furst
Pageof 76